Cegedim Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 1/6

CegedimDie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -2.2% zurückgegangen, während in der Branche Healthcare Services die Gewinne wachsen. Die Umsatzerlöse sind gewachsen mit einer durchschnittlichen Rate von 5.4% pro Jahr. Cegedim Die Eigenkapitalrendite des Unternehmens beträgt 0.4%, und die Nettomargen liegen bei 0.3%.

Wichtige Informationen

-2.2%

Wachstumsrate der Gewinne

-2.1%

EPS-Wachstumsrate

Healthcare Services Wachstum der Industrie	21.0%
Wachstumsrate der Einnahmen	5.4%
Eigenkapitalrendite	0.4%
Netto-Marge	0.3%
Letzte Ertragsaktualisierung	30 Jun 2024

Jüngste Aktualisierungen vergangener Leistungen

There May Be Reason For Hope In Cegedim's (EPA:CGM) Disappointing Earnings

Oct 04

Recent updates

Does Cegedim's (EPA:CGM) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 06

Cegedim's (EPA:CGM) Stock Price Has Reduced 26% In The Past Three Years

Nov 23

Aufschlüsselung der Einnahmen und Ausgaben

Wie Cegedim Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

ENXTPA:CGM Einnahmen, Ausgaben und Erträge (EUR Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten
30 Jun 24	634	2	146
31 Mar 24	625	-3	144
31 Dec 23	616	-7	141
30 Sep 23	602	1	136
30 Jun 23	589	10	131
31 Mar 23	572	12	126
31 Dec 22	555	14	121
30 Sep 22	548	14	119
30 Jun 22	541	15	116
31 Mar 22	533	21	112
31 Dec 21	525	26	108
30 Sep 21	518	24	103
30 Jun 21	512	22	98
31 Mar 21	504	16	100
31 Dec 20	497	11	102
30 Sep 20	496	10	108
30 Jun 20	494	8	114
31 Mar 20	499	5	115
31 Dec 19	504	3	116
30 Sep 19	495	-1	119
30 Jun 19	486	-5	121
31 Mar 19	477	0	123
31 Dec 18	468	4	124
30 Sep 18	464	8	120
30 Jun 18	461	12	116
31 Mar 18	459	10	119
31 Dec 17	457	7	122
30 Sep 17	452	-13	123
30 Jun 17	438	-17	125
31 Mar 17	435	-12	125
31 Dec 16	429	-29	123
30 Sep 16	438	13	121
30 Jun 16	435	9	120
31 Mar 16	432	1	113
31 Dec 15	426	19	109
30 Sep 15	364	0	102
30 Jun 15	380	-6	103
31 Mar 15	399	-4	107
31 Dec 14	412	-8	111
30 Sep 14	161	-26	46
30 Jun 14	266	-11	71
31 Mar 14	377	-5	99
31 Dec 13	488	-14	124

Qualität der Erträge: CGM hat einen großen einmalig Verlust von €13.3M, der sich auf die Finanzergebnisse der letzten 12 Monate auswirkt, an 30th June, 2024.

Wachsende Gewinnspanne: CGMDie aktuellen Gewinnspannen (0.3%) sind niedriger als im letzten Jahr (1.6%).

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: CGM ist in den letzten 5 Jahren profitabel geworden und hat seinen Gewinn um -2.2% pro Jahr gesteigert.

Beschleunigtes Wachstum: CGMDas Unternehmen hat im vergangenen Jahr ein negatives Gewinnwachstum verzeichnet, so dass es nicht mit seinem 5-Jahres-Durchschnitt verglichen werden kann.

Erträge im Vergleich zur Industrie: CGM hatte im vergangenen Jahr ein negatives Gewinnwachstum (-79.2%), was einen Vergleich mit dem Branchendurchschnitt Healthcare Services (9.3%) erschwert.

Eigenkapitalrendite

Hohe Eigenkapitalrendite: CGMDie Eigenkapitalrendite des Unternehmens (0.4%) wird als niedrig angesehen.

Cegedim Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

There May Be Reason For Hope In Cegedim's (EPA:CGM) Disappointing Earnings

First half 2024 earnings released: EPS: €0.046 (vs €0.64 loss in 1H 2023)

Third quarter 2023 earnings released: EPS: €0.051 (vs €0.68 in 3Q 2022)

Cegedim SA to Report First Half, 2024 Results on Sep 26, 2024

First half 2023 earnings released: €0.64 loss per share (vs €0.36 loss in 1H 2022)

First half 2023 earnings released: €0.64 loss per share (vs €0.36 loss in 1H 2022)

Recent updates

There May Be Reason For Hope In Cegedim's (EPA:CGM) Disappointing Earnings

First half 2024 earnings released: EPS: €0.046 (vs €0.64 loss in 1H 2023)

Price target decreased by 7.4% to €16.70

Cegedim SA Provides Earnings Guidance for the Full Year 2024

Cegedim SA's (EPA:CGM) CEO Will Probably Struggle To See A Pay Rise This Year

Price target decreased by 7.9% to €19.37

New major risk - Financial position

Investor sentiment deteriorates as stock falls 19%

Third quarter 2023 earnings released: EPS: €0.051 (vs €0.68 in 3Q 2022)

Getting In Cheap On Cegedim SA (EPA:CGM) Might Be Difficult

Consensus EPS estimates fall by 18%

Cegedim SA to Report First Half, 2024 Results on Sep 26, 2024

First half 2023 earnings released: €0.64 loss per share (vs €0.36 loss in 1H 2022)

Cegedim Provides Revenue Guidance for the Full Year 2023

First half 2023 earnings released: €0.64 loss per share (vs €0.36 loss in 1H 2022)

New minor risk - Earnings quality

Cegedim SA Provides Revenue Guidance for the Full Year 2023

These 4 Measures Indicate That Cegedim (EPA:CGM) Is Using Debt Extensively

Consensus EPS estimates increase by 16%

When Should You Buy Cegedim SA (EPA:CGM)?

Full year 2022 earnings: EPS exceeds analyst expectations

Price target increased by 7.1% to €21.40

Cegedim SA Provides Group Revenue Guidance for the Year 2023

Less than half of directors are independent

Cegedim SA to Report First Half, 2023 Results on Sep 20, 2023

Consensus forecasts updated

Cegedim SA to Report Fiscal Year 2022 Results on Mar 23, 2023

Consensus forecasts updated

Cegedim Provides Revenue Guidance for 2022

These 4 Measures Indicate That Cegedim (EPA:CGM) Is Using Debt Extensively

First half 2022 earnings released: €0.40 loss per share (vs €0.47 profit in 1H 2021)

Cegedim SA (ENXTPA:CGM) acquired Merito, SAS.

Upcoming dividend of €0.50 per share

Price target decreased to €28.83

Less than half of directors are independent

Cegedim, Malakoff Humanis, Groupe VYV, PRO BTP in Talks for Acquisition of Equity Stake in Cegedim Santé

Is Now The Time To Put Cegedim (EPA:CGM) On Your Watchlist?

Investor sentiment improved over the past week

Cegedim SA Provides Revenue Guidance for the Year 2022

Cegedim SA to Report First Half, 2022 Results on Sep 20, 2022

Cegedim Provides Revenue Guidance for the Year 2021

First half 2021 earnings released: EPS €0.47 (vs €0.34 loss in 1H 2020)

Consensus forecasts updated

Is Cegedim SA (EPA:CGM) Trading At A 26% Discount?

Should You Think About Buying Cegedim SA (EPA:CGM) Now?

Consensus forecasts updated

Cegedim Provides Revenue Guidance for the Year 2021

Cegedim (EPA:CGM) Seems To Use Debt Quite Sensibly

Cegedim's (EPA:CGM) Shareholders Are Down 33% On Their Shares

Full year 2020 earnings released: EPS €0.78 (vs €0.20 in FY 2019)

Cegedim SA Provides Earnings Guidance for the Year 2021

Are Investors Undervaluing Cegedim SA (EPA:CGM) By 43%?

New 90-day low: €23.20

What Is Cegedim SA's (EPA:CGM) Share Price Doing?

Analysts update estimates

What Is The Ownership Structure Like For Cegedim SA (EPA:CGM)?

Cegedim SA (EPA:CGM) Delivered A Weaker ROE Than Its Industry

What Does Cegedim's (EPA:CGM) CEO Pay Reveal?

Does Cegedim's (EPA:CGM) Statutory Profit Adequately Reflect Its Underlying Profit?

Market bids up stock over the past week

New 90-day high: €27.50

Cegedim's (EPA:CGM) Stock Price Has Reduced 26% In The Past Three Years

New 90-day low: €22.30

Analysts lower EPS estimates to €0.88

Analysts lower EPS estimates to €1.21

New 90-day low: €23.50

New 90-day low - €26.40

Price target raised to €31.88

Aufschlüsselung der Einnahmen und Ausgaben